Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
Ridaforolimus (AP23573; MK-8669), a potent mTOR inhibitor, has broad antitumor activity and can be optimally administered using intermittent dosing regimens. [electronic resource] by
- Rivera, Victor M
- Squillace, Rachel M
- Miller, David
- Berk, Lori
- Wardwell, Scott D
- Ning, Yaoyu
- Pollock, Roy
- Narasimhan, Narayana I
- Iuliucci, John D
- Wang, Frank
- Clackson, Tim
Producer: 20111109
In:
Molecular cancer therapeutics vol. 10
Availability: No items available.
|
|
7.
|
Crizotinib-resistant mutants of EML4-ALK identified through an accelerated mutagenesis screen. [electronic resource] by
- Zhang, Sen
- Wang, Frank
- Keats, Jeffrey
- Zhu, Xiaotian
- Ning, Yaoyu
- Wardwell, Scott D
- Moran, Lauren
- Mohemmad, Qurish K
- Anjum, Rana
- Wang, Yihan
- Narasimhan, Narayana I
- Dalgarno, David
- Shakespeare, William C
- Miret, Juan J
- Clackson, Tim
- Rivera, Victor M
Producer: 20120720
In:
Chemical biology & drug design vol. 78
Availability: No items available.
|
|
8.
|
Ponatinib inhibits polyclonal drug-resistant KIT oncoproteins and shows therapeutic potential in heavily pretreated gastrointestinal stromal tumor (GIST) patients. [electronic resource] by
- Garner, Andrew P
- Gozgit, Joseph M
- Anjum, Rana
- Vodala, Sadanand
- Schrock, Alexa
- Zhou, Tianjun
- Serrano, Cesar
- Eilers, Grant
- Zhu, Meijun
- Ketzer, Julia
- Wardwell, Scott
- Ning, Yaoyu
- Song, Youngchul
- Kohlmann, Anna
- Wang, Frank
- Clackson, Tim
- Heinrich, Michael C
- Fletcher, Jonathan A
- Bauer, Sebastian
- Rivera, Victor M
Producer: 20150709
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 20
Availability: No items available.
|
|
9.
|
Novel N9-arenethenyl purines as potent dual Src/Abl tyrosine kinase inhibitors. [electronic resource] by
- Wang, Yihan
- Shakespeare, William C
- Huang, Wei-Sheng
- Sundaramoorthi, Raji
- Lentini, Scott
- Das, Sasmita
- Liu, Shuangying
- Banda, Geeta
- Wen, David
- Zhu, Xiaotian
- Xu, Qihong
- Keats, Jeffrey
- Wang, Frank
- Wardwell, Scott
- Ning, Yaoyu
- Snodgrass, Joseph T
- Broudy, Mark I
- Russian, Karin
- Dalgarno, David
- Clackson, Tim
- Sawyer, Tomi K
Producer: 20081027
In:
Bioorganic & medicinal chemistry letters vol. 18
Availability: No items available.
|
|
10.
|
The Potent ALK Inhibitor Brigatinib (AP26113) Overcomes Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in Preclinical Models. [electronic resource] by
- Zhang, Sen
- Anjum, Rana
- Squillace, Rachel
- Nadworny, Sara
- Zhou, Tianjun
- Keats, Jeff
- Ning, Yaoyu
- Wardwell, Scott D
- Miller, David
- Song, Youngchul
- Eichinger, Lindsey
- Moran, Lauren
- Huang, Wei-Sheng
- Liu, Shuangying
- Zou, Dong
- Wang, Yihan
- Mohemmad, Qurish
- Jang, Hyun Gyung
- Ye, Emily
- Narasimhan, Narayana
- Wang, Frank
- Miret, Juan
- Zhu, Xiaotian
- Clackson, Tim
- Dalgarno, David
- Shakespeare, William C
- Rivera, Victor M
Producer: 20180117
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 22
Availability: No items available.
|
|
11.
|
9-(Arenethenyl)purines as dual Src/Abl kinase inhibitors targeting the inactive conformation: design, synthesis, and biological evaluation. [electronic resource] by
- Huang, Wei-Sheng
- Zhu, Xiaotian
- Wang, Yihan
- Azam, Mohammad
- Wen, David
- Sundaramoorthi, Raji
- Thomas, R Mathew
- Liu, Shuangying
- Banda, Geetha
- Lentini, Scott P
- Das, Sasmita
- Xu, Qihong
- Keats, Jeff
- Wang, Frank
- Wardwell, Scott
- Ning, Yaoyu
- Snodgrass, Joseph T
- Broudy, Marc I
- Russian, Karin
- Daley, George Q
- Iuliucci, John
- Dalgarno, David C
- Clackson, Tim
- Sawyer, Tomi K
- Shakespeare, William C
Producer: 20090921
In:
Journal of medicinal chemistry vol. 52
Availability: No items available.
|
|
12.
|
AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance. [electronic resource] by
- O'Hare, Thomas
- Shakespeare, William C
- Zhu, Xiaotian
- Eide, Christopher A
- Rivera, Victor M
- Wang, Frank
- Adrian, Lauren T
- Zhou, Tianjun
- Huang, Wei-Sheng
- Xu, Qihong
- Metcalf, Chester A
- Tyner, Jeffrey W
- Loriaux, Marc M
- Corbin, Amie S
- Wardwell, Scott
- Ning, Yaoyu
- Keats, Jeffrey A
- Wang, Yihan
- Sundaramoorthi, Raji
- Thomas, Mathew
- Zhou, Dong
- Snodgrass, Joseph
- Commodore, Lois
- Sawyer, Tomi K
- Dalgarno, David C
- Deininger, Michael W N
- Druker, Brian J
- Clackson, Tim
Producer: 20091208
In:
Cancer cell vol. 16
Availability: No items available.
|
|
13.
|
Discovery of 5-(arenethynyl) hetero-monocyclic derivatives as potent inhibitors of BCR-ABL including the T315I gatekeeper mutant. [electronic resource] by
- Thomas, Mathew
- Huang, Wei-Sheng
- Wen, David
- Zhu, Xiaotian
- Wang, Yihan
- Metcalf, Chester A
- Liu, Shuangying
- Chen, Ingrid
- Romero, Jan
- Zou, Dong
- Sundaramoorthi, Raji
- Li, Feng
- Qi, Jiwei
- Cai, Lisi
- Zhou, Tianjun
- Commodore, Lois
- Xu, Qihong
- Keats, Jeff
- Wang, Frank
- Wardwell, Scott
- Ning, Yaoyu
- Snodgrass, Joseph T
- Broudy, Marc I
- Russian, Karin
- Iuliucci, John
- Rivera, Victor M
- Sawyer, Tomi K
- Dalgarno, David C
- Clackson, Tim
- Shakespeare, William C
Producer: 20111122
In:
Bioorganic & medicinal chemistry letters vol. 21
Availability: No items available.
|
|
14.
|
Discovery of Brigatinib (AP26113), a Phosphine Oxide-Containing, Potent, Orally Active Inhibitor of Anaplastic Lymphoma Kinase. [electronic resource] by
- Huang, Wei-Sheng
- Liu, Shuangying
- Zou, Dong
- Thomas, Mathew
- Wang, Yihan
- Zhou, Tianjun
- Romero, Jan
- Kohlmann, Anna
- Li, Feng
- Qi, Jiwei
- Cai, Lisi
- Dwight, Timothy A
- Xu, Yongjin
- Xu, Rongsong
- Dodd, Rory
- Toms, Angela
- Parillon, Lois
- Lu, Xiaohui
- Anjum, Rana
- Zhang, Sen
- Wang, Frank
- Keats, Jeffrey
- Wardwell, Scott D
- Ning, Yaoyu
- Xu, Qihong
- Moran, Lauren E
- Mohemmad, Qurish K
- Jang, Hyun Gyung
- Clackson, Tim
- Narasimhan, Narayana I
- Rivera, Victor M
- Zhu, Xiaotian
- Dalgarno, David
- Shakespeare, William C
Producer: 20170529
In:
Journal of medicinal chemistry vol. 59
Availability: No items available.
|
|
15.
|
Discovery of 3-[2-(imidazo[1,2-b]pyridazin-3-yl)ethynyl]-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide (AP24534), a potent, orally active pan-inhibitor of breakpoint cluster region-abelson (BCR-ABL) kinase including the T315I gatekeeper mutant. [electronic resource] by
- Huang, Wei-Sheng
- Metcalf, Chester A
- Sundaramoorthi, Raji
- Wang, Yihan
- Zou, Dong
- Thomas, R Mathew
- Zhu, Xiaotian
- Cai, Lisi
- Wen, David
- Liu, Shuangying
- Romero, Jan
- Qi, Jiwei
- Chen, Ingrid
- Banda, Geetha
- Lentini, Scott P
- Das, Sasmita
- Xu, Qihong
- Keats, Jeff
- Wang, Frank
- Wardwell, Scott
- Ning, Yaoyu
- Snodgrass, Joseph T
- Broudy, Marc I
- Russian, Karin
- Zhou, Tianjun
- Commodore, Lois
- Narasimhan, Narayana I
- Mohemmad, Qurish K
- Iuliucci, John
- Rivera, Victor M
- Dalgarno, David C
- Sawyer, Tomi K
- Clackson, Tim
- Shakespeare, William C
Producer: 20100708
In:
Journal of medicinal chemistry vol. 53
Availability: No items available.
|